Form 4: Nurix Therapeutics' Chief Legal Officer Reports Stock Transactions
SEC Form 4 Filing
Christine Ring, Chief Legal Officer of Nurix Therapeutics, reports the acquisition and disposal of common stock and restricted stock units to cover tax obligations.
Summary
- Christine Ring, the Chief Legal Officer of Nurix Therapeutics, filed a Form 4 detailing changes in beneficial ownership.
- On April 30, 2024, Ring acquired 1,924 shares of common stock and 2,000 shares of common stock through the vesting of restricted stock units (RSUs).
- On the same day, Ring disposed of 1,513 shares of common stock at a weighted average price of $12.0422 to cover tax withholding obligations related to the vesting of RSUs.
- Following these transactions, Ring beneficially owns 19,838 shares of common stock directly and 16,000 restricted stock units.
- The sales were mandated by Nurix Therapeutics' equity incentive plans to cover tax obligations via a 'sell to cover' transaction.
Sentiment
Score: 5
Explanation: This is a routine regulatory filing related to stock transactions by a company officer. It doesn't inherently indicate positive or negative sentiment, as it reflects standard compensation practices and tax obligations.
Industry Context
Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company executives and directors. This filing indicates activity related to equity compensation and tax obligations, which is common for publicly traded companies.
Stakeholder Impact
- The transactions have a minor impact on shareholders as they involve the sale of shares to cover tax obligations, which is a common practice and doesn't significantly alter the company's financial position.
Key Dates
| Date | Description |
|---|---|
| 04/30/2022 | First quarterly vesting increment for 1,924 RSUs. |
| 07/30/2023 | First quarterly vesting increment for 2,000 RSUs. |
| 04/30/2024 | Date of reported transactions: acquisition of stock via RSU vesting and sale of stock to cover tax obligations. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.